Logo image of ZAL.DE

ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

Europe - FRA:ZAL - DE000ZAL1111 - Common Stock

25.9 EUR
-0.28 (-1.07%)
Last: 10/20/2025, 2:18:24 PM
Fundamental Rating

6

ZAL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 53 industry peers in the Specialty Retail industry. While ZAL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ZAL is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make ZAL a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ZAL was profitable.
ZAL had a positive operating cash flow in the past year.
Each year in the past 5 years ZAL has been profitable.
In the past 5 years ZAL always reported a positive cash flow from operatings.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

ZAL has a better Return On Assets (3.33%) than 67.92% of its industry peers.
With a decent Return On Equity value of 9.70%, ZAL is doing good in the industry, outperforming 67.92% of the companies in the same industry.
ZAL has a Return On Invested Capital of 6.07%. This is in the better half of the industry: ZAL outperforms 64.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZAL is significantly below the industry average of 10.25%.
The last Return On Invested Capital (6.07%) for ZAL is above the 3 year average (3.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.33%
ROE 9.7%
ROIC 6.07%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 2.47%, ZAL is doing good in the industry, outperforming 66.04% of the companies in the same industry.
ZAL's Profit Margin has improved in the last couple of years.
ZAL has a Operating Margin (3.68%) which is in line with its industry peers.
ZAL's Operating Margin has improved in the last couple of years.
The Gross Margin of ZAL (40.66%) is better than 60.38% of its industry peers.
In the last couple of years the Gross Margin of ZAL has remained more or less at the same level.
Industry RankSector Rank
OM 3.68%
PM (TTM) 2.47%
GM 40.66%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

ZAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ZAL has less shares outstanding
Compared to 5 years ago, ZAL has more shares outstanding
The debt/assets ratio for ZAL has been reduced compared to a year ago.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.95 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.95, ZAL is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
ZAL has a debt to FCF ratio of 7.83. This is a slightly negative value and a sign of low solvency as ZAL would need 7.83 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.83, ZAL is in line with its industry, outperforming 56.60% of the companies in the same industry.
ZAL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
ZAL has a Debt to Equity ratio of 0.40. This is in the better half of the industry: ZAL outperforms 67.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 7.83
Altman-Z 2.95
ROIC/WACC0.96
WACC6.32%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

ZAL has a Current Ratio of 1.38. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
ZAL's Current ratio of 1.38 is fine compared to the rest of the industry. ZAL outperforms 64.15% of its industry peers.
A Quick Ratio of 0.98 indicates that ZAL may have some problems paying its short term obligations.
The Quick ratio of ZAL (0.98) is better than 75.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.98
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.27% over the past year.
The Earnings Per Share has been growing by 23.33% on average over the past years. This is a very strong growth
Looking at the last year, ZAL shows a small growth in Revenue. The Revenue has grown by 7.12% in the last year.
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)76.27%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%0%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.26%

3.2 Future

The Earnings Per Share is expected to grow by 26.24% on average over the next years. This is a very strong growth
ZAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.15% yearly.
EPS Next Y21.29%
EPS Next 2Y24.76%
EPS Next 3Y23.78%
EPS Next 5Y26.24%
Revenue Next Year14.18%
Revenue Next 2Y12.97%
Revenue Next 3Y10.37%
Revenue Next 5Y10.15%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

ZAL is valuated rather expensively with a Price/Earnings ratio of 24.90.
Based on the Price/Earnings ratio, ZAL is valued a bit cheaper than 69.81% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZAL to the average of the S&P500 Index (27.42), we can say ZAL is valued inline with the index average.
A Price/Forward Earnings ratio of 17.15 indicates a rather expensive valuation of ZAL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZAL indicates a somewhat cheap valuation: ZAL is cheaper than 62.26% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ZAL to the average of the S&P500 Index (22.94), we can say ZAL is valued slightly cheaper.
Industry RankSector Rank
PE 24.9
Fwd PE 17.15
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ZAL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ZAL is cheaper than 69.81% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZAL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 31.81
EV/EBITDA 7.14
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ZAL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ZAL has a very decent profitability rating, which may justify a higher PE ratio.
ZAL's earnings are expected to grow with 23.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)1.07
EPS Next 2Y24.76%
EPS Next 3Y23.78%

0

5. Dividend

5.1 Amount

ZAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZALANDO SE

FRA:ZAL (10/20/2025, 2:18:24 PM)

25.9

-0.28 (-1.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06
Inst Owners62.05%
Inst Owner ChangeN/A
Ins Owners10.09%
Ins Owner ChangeN/A
Market Cap6.84B
Analysts78.13
Price Target37.5 (44.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)444.88%
Min EPS beat(2)-2.31%
Max EPS beat(2)892.08%
EPS beat(4)3
Avg EPS beat(4)227.19%
Min EPS beat(4)-2.31%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)70.96%
EPS beat(12)6
Avg EPS beat(12)0.99%
EPS beat(16)7
Avg EPS beat(16)-20.02%
Revenue beat(2)1
Avg Revenue beat(2)0.58%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)1.19%
Revenue beat(4)2
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)1.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)0.1%
PT rev (3m)-4.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.32%
EPS NY rev (1m)-7.69%
EPS NY rev (3m)-2.14%
Revenue NQ rev (1m)-2.56%
Revenue NQ rev (3m)16.29%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)6.99%
Valuation
Industry RankSector Rank
PE 24.9
Fwd PE 17.15
P/S 0.63
P/FCF 31.81
P/OCF 16.48
P/B 2.45
P/tB 2.9
EV/EBITDA 7.14
EPS(TTM)1.04
EY4.02%
EPS(NY)1.51
Fwd EY5.83%
FCF(TTM)0.81
FCFY3.14%
OCF(TTM)1.57
OCFY6.07%
SpS41.42
BVpS10.57
TBVpS8.94
PEG (NY)1.17
PEG (5Y)1.07
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 9.7%
ROCE 9.91%
ROIC 6.07%
ROICexc 17.63%
ROICexgc 25.4%
OM 3.68%
PM (TTM) 2.47%
GM 40.66%
FCFM 1.97%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ROICexc(3y)9.52%
ROICexc(5y)14.27%
ROICexgc(3y)13.4%
ROICexgc(5y)19.23%
ROCE(3y)5.45%
ROCE(5y)7.5%
ROICexcg growth 3Y8.96%
ROICexcg growth 5Y22.36%
ROICexc growth 3Y2.72%
ROICexc growth 5Y17.49%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 7.83
Debt/EBITDA 1.48
Cap/Depr 55.44%
Cap/Sales 1.83%
Interest Coverage 250
Cash Conversion 54.37%
Profit Quality 79.43%
Current Ratio 1.38
Quick Ratio 0.98
Altman-Z 2.95
F-Score7
WACC6.32%
ROIC/WACC0.96
Cap/Depr(3y)86.74%
Cap/Depr(5y)104.05%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.86%
Profit Quality(3y)549.88%
Profit Quality(5y)378.62%
High Growth Momentum
Growth
EPS 1Y (TTM)76.27%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%0%
EPS Next Y21.29%
EPS Next 2Y24.76%
EPS Next 3Y23.78%
EPS Next 5Y26.24%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.26%
Revenue Next Year14.18%
Revenue Next 2Y12.97%
Revenue Next 3Y10.37%
Revenue Next 5Y10.15%
EBIT growth 1Y40.95%
EBIT growth 3Y-1.58%
EBIT growth 5Y18.79%
EBIT Next Year116.51%
EBIT Next 3Y41.81%
EBIT Next 5Y37.12%
FCF growth 1Y-69.35%
FCF growth 3Y16.44%
FCF growth 5Y84.9%
OCF growth 1Y-58.04%
OCF growth 3Y2.01%
OCF growth 5Y14.86%